Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 68 | 2,849+1.1%/yr | +1.1%/yr | 3.71.3× | 2% | 3,400 in 2030+3%/yr |
| Decompression & minimally invasive spine | 72 | 2,815−4.4%/yr | −4.4%/yr | 3.71.2× | 14% | 3,290 in 2030+2.6%/yr |
| Cervical fusion & disc arthroplasty | 36 | 1,337+2.4%/yr | +2.4%/yr | 1.71.4× | 6% | 1,730 in 2030+4.4%/yr |
| Kyphoplasty & vertebroplasty | 15 | 1,110+2.9%/yr | +2.9%/yr | 1.51.8× | 90% | 1,600 in 2030+6.3%/yr |
| SI joint fusion | 5 | 365+24%/yr | +24%/yr | 0.42.2× | 67% | 950 in 2030+17%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 316 | 56,942−0.2%/yr | −0.2%/yr | 73.40.7× | 55% | 62,400 in 2030+1.5%/yr |
| Skin substitutes & wound grafts | 83 | 15,125+16%/yr | +16%/yr | 12.61.0× | 85% | 26,900 in 2030+10%/yr |
| Bone graft & orthobiologics | 19 | 661−4.1%/yr | −4.1%/yr | 0.91.1× | 2% | 740 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 185 | 17,395+0.3%/yr | +0.3%/yr | 22.42.7× | 93% | 19,600 in 2030+2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 23 | 1,632+19%/yr | +19%/yr | 2.02.6× | 90% | 3,070 in 2030+11%/yr |
| Spinal cord & DRG stimulation | 28 | 930+0.9%/yr | +0.9%/yr | 1.22.2× | 78% | 1,060 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 94 | 10,087−0.8%/yr | −0.8%/yr | 13.02.6× | 100% | 10,200 in 2030+0.2%/yr |
| Peripheral arterial intervention | 38 | 4,850−6.8%/yr | −6.8%/yr | 6.21.3× | 74% | 4,560 in 2030−1%/yr |
| Dialysis access | 33 | 3,680−7.6%/yr | −7.6%/yr | 5.21.1× | 88% | 4,140 in 2030+2%/yr |
| Thrombectomy, IVC filters & venous stents | 11 | 1,180+4.1%/yr | +4.1%/yr | 1.61.4× | 19% | 1,490 in 2030+3.9%/yr |
| Carotid revascularization | 21 | 884−3%/yr | −3%/yr | 1.21.5× | 0% | 1,070 in 2030+3.3%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 322−6.9%/yr | −6.9%/yr | 0.41.4× | 0% | 370 in 2030+2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 84 | 5,543−0.6%/yr | −0.6%/yr | 7.91.4× | 12% | 6,180 in 2030+1.8%/yr |
| Cholecystectomy & appendectomy | 74 | 3,384−3.1%/yr | −3.1%/yr | 4.71.3× | 5% | 3,490 in 2030+0.5%/yr |
| Colorectal resection | 9 | 1,209−3.2%/yr | −3.2%/yr | 1.71.2× | 0% | 1,270 in 2030+0.9%/yr |
| Antireflux & hiatal hernia surgery | 15 | 620−1%/yr | −1%/yr | 0.81.2× | 0% | 820 in 2030+4.8%/yr |
| Breast reconstruction | 2 | 390−7.9%/yr | −7.9%/yr | 0.51.3× | 11% | 540 in 2030+5.6%/yr |
| Bariatric surgery | 0 | 111−16%/yr | −16%/yr | 0.10.9× | 0% | 120 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 79 | 6,117−8.2%/yr | −8.2%/yr | 8.21.9× | 55% | 6,220 in 2030+0.3%/yr |
| Kidney stone management | 76 | 3,933−3.7%/yr | −3.7%/yr | 5.41.6× | 10% | 4,060 in 2030+0.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 38 | 2,602+2%/yr | +2%/yr | 3.52.1× | 38% | 2,760 in 2030+1%/yr |
| Hysterectomy, hysteroscopy & ablation | 21 | 1,973+0.3%/yr | +0.3%/yr | 2.91.3× | 22% | 2,360 in 2030+3%/yr |
| Prostatectomy & nephrectomy | 14 | 942−0.8%/yr | −0.8%/yr | 1.41.2× | 0% | 1,200 in 2030+4.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 46 | 6,368+5.8%/yr | +5.8%/yr | 8.72.1× | 93% | 7,720 in 2030+3.3%/yr |
| Sleep apnea & airway implants | 8 | 239+57%/yr | +57%/yr | 0.32.3× | 9% | 180 in 2030−4.4%/yr |
| Cochlear implants | 8 | 188+10%/yr | +10%/yr | 0.31.6× | 0% | 200 in 2030+1%/yr |
| Ear tubes & middle ear surgery | 1 | 177−6.4%/yr | −6.4%/yr | 0.21.2× | 100% | 150 in 2030−2.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 73 | 4,473−1.9%/yr | −1.9%/yr | 6.41.0× | 70% | 4,560 in 2030+0.3%/yr |
| Tumor & fibroid embolization | 11 | 723+24%/yr | +24%/yr | 1.01.9× | 78% | 1,640 in 2030+15%/yr |
| Tumor ablation | 3 | 264+12%/yr | +12%/yr | 0.41.4× | 0% | 460 in 2030+9.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 119 | 19,293+31%/yr | +31%/yr | 25.61.3× | 94% | 36,700 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| LAA occlusion & loop recorders | 106 | 4,739+15%/yr | +15%/yr | 5.62.3× | 41% | 7,950 in 2030+9%/yr |
| Pacemaker, ICD & CRT implantation | 85 | 4,095−2.6%/yr | −2.6%/yr | 5.71.5× | 26% | 4,390 in 2030+1.2%/yr |
| EP ablation | 62 | 3,909+7.7%/yr | +7.7%/yr | 4.41.6× | 0% | 6,260 in 2030+8.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 142 | 5,873−3.4%/yr | −3.4%/yr | 6.51.5× | 17% | 6,410 in 2030+1.5%/yr |
| Structural heart (TAVR, TEER) | 74 | 1,643+5.5%/yr | +5.5%/yr | 1.91.3× | 0% | 2,270 in 2030+5.5%/yr |
| Mechanical circulatory support | 2 | 409−4.1%/yr | −4.1%/yr | 0.61.3× | 0% | 400 in 2030−0.5%/yr |
| PFO & septal closure | 2 | 121+7.6%/yr | +7.6%/yr | 0.21.7× | 0% | 170 in 2030+5.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 12 | 342+14%/yr | +14%/yr | 0.51.0× | 0% | 770 in 2030+14%/yr |
| DBS & VNS | 4 | 305−10%/yr | −10%/yr | 0.41.3× | 0% | 540 in 2030+9.8%/yr |
| Stroke thrombectomy | 10 | 233+2.7%/yr | +2.7%/yr | 0.30.8× | 0% | 280 in 2030+3%/yr |
| CSF shunts | 3 | 152−8%/yr | −8%/yr | 0.21.0× | 0% | 170 in 2030+1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 159 | 41,851+0.2%/yr | +0.2%/yr | 55.51.2× | 97% | 45,100 in 2030+1.3%/yr |
| Vitreoretinal surgery | 32 | 2,892−3.5%/yr | −3.5%/yr | 3.91.5× | 99% | 3,110 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 351 | 76,510−1%/yr | −1%/yr | 107.41.0× | 56% | 84,500 in 2030+1.7%/yr |
| Bronchoscopy & lung nodule | 38 | 3,079+16%/yr | +16%/yr | 4.21.8× | 0% | 5,590 in 2030+10%/yr |
| ERCP & endoscopic ultrasound | 36 | 2,770+2.8%/yr | +2.8%/yr | 3.81.1× | 2% | 3,300 in 2030+3%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.